Literature DB >> 24509527

Persistence and activation of malaria hypnozoites in long-term primary hepatocyte cultures.

Laurent Dembélé1, Jean-François Franetich1, Audrey Lorthiois2, Audrey Gego2, Anne-Marie Zeeman3, Clemens H M Kocken3, Roger Le Grand4, Nathalie Dereuddre-Bosquet4, Geert-Jan van Gemert5, Robert Sauerwein5, Jean-Christophe Vaillant6, Laurent Hannoun6, Matthew J Fuchter7, Thierry T Diagana8, Nicholas A Malmquist9, Artur Scherf9, Georges Snounou2, Dominique Mazier10.   

Abstract

Malaria relapses, resulting from the activation of quiescent hepatic hypnozoites of Plasmodium vivax and Plasmodium ovale, hinder global efforts to control and eliminate malaria. As primaquine, the only drug capable of eliminating hypnozoites, is unsuitable for mass administration, an alternative drug is needed urgently. Currently, analyses of hypnozoites, including screening of compounds that would eliminate them, can only be made using common macaque models, principally Macaca rhesus and Macaca fascicularis, experimentally infected with the relapsing Plasmodium cynomolgi. Here, we present a protocol for long-term in vitro cultivation of P. cynomolgi-infected M. fascicularis primary hepatocytes during which hypnozoites persist and activate to resume normal development. In a proof-of-concept experiment, we obtained evidence that exposure to an inhibitor of histone modification enzymes implicated in epigenetic control of gene expression induces an accelerated rate of hypnozoite activation. The protocol presented may further enable investigations of hypnozoite biology and the search for compounds that kill hypnozoites or disrupt their quiescence.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24509527     DOI: 10.1038/nm.3461

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  35 in total

Review 1.  The silent path to thousands of merozoites: the Plasmodium liver stage.

Authors:  Miguel Prudêncio; Ana Rodriguez; Maria M Mota
Journal:  Nat Rev Microbiol       Date:  2006-11       Impact factor: 60.633

2.  Extended primary culture of human hepatocytes in a collagen gel sandwich system.

Authors:  Y Kono; S Yang; E A Roberts
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-06       Impact factor: 2.416

3.  Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration.

Authors:  J C Dunn; M L Yarmush; H G Koebe; R G Tompkins
Journal:  FASEB J       Date:  1989-02       Impact factor: 5.191

4.  Relapses in primate malaria: discovery of two populations of exoerythrocytic stages. Preliminary note.

Authors:  W A Krotoski; D M Krotoski; P C Garnham; R S Bray; R Killick-Kendrick; C C Draper; G A Targett; M W Guy
Journal:  Br Med J       Date:  1980-01-19

5.  Observations on early and late post-sporozoite tissue stages in primate malaria. I. Discovery of a new latent form of Plasmodium cynomolgi (the hypnozoite), and failure to detect hepatic forms within the first 24 hours after infection.

Authors:  W A Krotoski; P C Garnham; R S Bray; D M Krotoski; R Killick-Kendrick; C C Draper; G A Targett; M W Guy
Journal:  Am J Trop Med Hyg       Date:  1982-01       Impact factor: 2.345

6.  Plasmodium cynomolgi infections in the rhesus monkey.

Authors:  L H Schmidt
Journal:  Am J Trop Med Hyg       Date:  1982-05       Impact factor: 2.345

Review 7.  Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.

Authors:  Timothy N C Wells; Jeremy N Burrows; J Kevin Baird
Journal:  Trends Parasitol       Date:  2010-02-03

8.  Efficient restricted gene expression in beta cells by lentivirus-mediated gene transfer into pancreatic stem/progenitor cells.

Authors:  M Castaing; A Guerci; J Mallet; P Czernichow; P Ravassard; R Scharfmann
Journal:  Diabetologia       Date:  2005-03-10       Impact factor: 10.122

9.  Genome-wide analysis of heterochromatin associates clonally variant gene regulation with perinuclear repressive centers in malaria parasites.

Authors:  Jose-Juan Lopez-Rubio; Liliana Mancio-Silva; Artur Scherf
Journal:  Cell Host Microbe       Date:  2009-02-19       Impact factor: 21.023

10.  Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery.

Authors:  Laurent Dembele; Audrey Gego; Anne-Marie Zeeman; Jean-François Franetich; Olivier Silvie; Armelle Rametti; Roger Le Grand; Nathalie Dereuddre-Bosquet; Robert Sauerwein; Geert-Jan van Gemert; Jean-Christophe Vaillant; Alan W Thomas; Georges Snounou; Clemens H M Kocken; Dominique Mazier
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

View more
  86 in total

Review 1.  8-Aminoquinoline Therapy for Latent Malaria.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2019-07-31       Impact factor: 26.132

Review 2.  Malaria vaccine clinical trials: what's on the horizon.

Authors:  Alberto Moreno; Chester Joyner
Journal:  Curr Opin Immunol       Date:  2015-07-13       Impact factor: 7.486

Review 3.  Malaria medicines: a glass half full?

Authors:  Timothy N C Wells; Rob Hooft van Huijsduijnen; Wesley C Van Voorhis
Journal:  Nat Rev Drug Discov       Date:  2015-05-22       Impact factor: 84.694

Review 4.  Susceptibility Testing of Medically Important Parasites.

Authors:  Abebe Genetu Bayih; Anjan Debnath; Edward Mitre; Christopher D Huston; Benoît Laleu; Didier Leroy; Benjamin Blasco; Brice Campo; Timothy N C Wells; Paul A Willis; Peter Sjö; Wesley C Van Voorhis; Dylan R Pillai
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

Review 5.  Advances in molecular genetic systems in malaria.

Authors:  Tania F de Koning-Ward; Paul R Gilson; Brendan S Crabb
Journal:  Nat Rev Microbiol       Date:  2015-06       Impact factor: 60.633

Review 6.  Phenotypic Screens in Antimalarial Drug Discovery.

Authors:  Marisa L Hovlid; Elizabeth A Winzeler
Journal:  Trends Parasitol       Date:  2016-05-27

Review 7.  Current therapies and future possibilities for drug development against liver-stage malaria.

Authors:  Rene Raphemot; Dora Posfai; Emily R Derbyshire
Journal:  J Clin Invest       Date:  2016-06-01       Impact factor: 14.808

8.  Malarial liver parasites awaken in culture.

Authors:  John W Barnwell; Mary R Galinski
Journal:  Nat Med       Date:  2014-03       Impact factor: 53.440

9.  Lead optimization of imidazopyrazines: a new class of antimalarial with activity on Plasmodium liver stages.

Authors:  Bin Zou; Advait Nagle; Arnab K Chatterjee; Seh Yong Leong; Liying Jocelyn Tan; Wei Lin Sandra Sim; Pranab Mishra; Prasuna Guntapalli; David C Tully; Suresh B Lakshminarayana; Chek Shik Lim; Yong Cheng Tan; Siti Nurdiana Abas; Christophe Bodenreider; Kelli L Kuhen; Kerstin Gagaring; Rachel Borboa; Jonathan Chang; Chun Li; Thomas Hollenbeck; Tove Tuntland; Anne-Marie Zeeman; Clemens H M Kocken; Case McNamara; Nobutaka Kato; Elizabeth A Winzeler; Bryan K S Yeung; Thierry T Diagana; Paul W Smith; Jason Roland
Journal:  ACS Med Chem Lett       Date:  2014-07-06       Impact factor: 4.345

10.  Development of a Photo-Cross-Linkable Diaminoquinazoline Inhibitor for Target Identification in Plasmodium falciparum.

Authors:  Alexandra S Lubin; Ainoa Rueda-Zubiaurre; Holly Matthews; Hella Baumann; Fabio R Fisher; Julia Morales-Sanfrutos; Kate S Hadavizadeh; Flore Nardella; Edward W Tate; Jake Baum; Artur Scherf; Matthew J Fuchter
Journal:  ACS Infect Dis       Date:  2018-02-05       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.